EP 1121360 A1 20010808 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
IL-8-REZEPTOR-ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR DE L'INTERLEUKINE-8 (IL-8)
Publication
Application
Priority
- US 9923776 W 19991012
- US 10401698 P 19981013
Abstract (en)
[origin: WO0021963A1] This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
IPC 1-7
IPC 8 full level
A61K 31/437 (2006.01); A61P 1/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 513/04 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 13/12 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 513/04 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0021963 A1 20000420; EP 1121360 A1 20010808; EP 1121360 A4 20020123; JP 2002527441 A 20020827
DOCDB simple family (application)
US 9923776 W 19991012; EP 99956537 A 19991012; JP 2000575869 A 19991012